| __timestamp | BeiGene, Ltd. | Gilead Sciences, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 6930000 | 2983000000 |
| Thursday, January 1, 2015 | 7311000 | 3426000000 |
| Friday, January 1, 2016 | 20097000 | 3398000000 |
| Sunday, January 1, 2017 | 62602000 | 3878000000 |
| Monday, January 1, 2018 | 195385000 | 4056000000 |
| Tuesday, January 1, 2019 | 388249000 | 4381000000 |
| Wednesday, January 1, 2020 | 600176000 | 5151000000 |
| Friday, January 1, 2021 | 990123000 | 5246000000 |
| Saturday, January 1, 2022 | 1277852000 | 5673000000 |
| Sunday, January 1, 2023 | 1504501000 | 6090000000 |
| Monday, January 1, 2024 | 6091000000 |
Unlocking the unknown
In the ever-evolving landscape of biotechnology, understanding the efficiency of Selling, General, and Administrative (SG&A) expenses is crucial. Over the past decade, Gilead Sciences, Inc. and BeiGene, Ltd. have showcased contrasting trajectories in their SG&A spending.
From 2014 to 2023, Gilead's SG&A expenses have steadily increased, peaking at approximately $6.09 billion in 2023. This represents a 104% increase from 2014, reflecting the company's expansive growth and strategic investments.
Conversely, BeiGene's SG&A expenses have skyrocketed by over 21,600% during the same period, reaching $1.5 billion in 2023. This dramatic rise underscores BeiGene's aggressive market penetration and expansion efforts.
These trends highlight the diverse strategies employed by these biotech leaders, offering valuable insights into their operational efficiencies and market strategies.
Comparing SG&A Expenses: Pfizer Inc. vs BeiGene, Ltd. Trends and Insights
Who Optimizes SG&A Costs Better? Bristol-Myers Squibb Company or BeiGene, Ltd.
Who Optimizes SG&A Costs Better? Gilead Sciences, Inc. or Pharming Group N.V.
Who Optimizes SG&A Costs Better? Gilead Sciences, Inc. or Alkermes plc
Gilead Sciences, Inc. and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Takeda Pharmaceutical Company Limited vs BeiGene, Ltd. Trends and Insights
BeiGene, Ltd. or Lantheus Holdings, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Rhythm Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: BeiGene, Ltd. vs Veracyte, Inc.
SG&A Efficiency Analysis: Comparing BeiGene, Ltd. and ACADIA Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Supernus Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and Ligand Pharmaceuticals Incorporated